Coloplast A/S - Best
Coloplast A/S - Bestyrelsesmedlemmers, direktørers eller nærtstående personers handel med Coloplast-aktier
11. Dezember 2024 09:54 ET | Coloplast A/S
Se venligst vedlagte pdf.   Vedhæftet fil 11122024_handel_med_aktier_GL ...
Coloplast A/S - Trad
Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons
11. Dezember 2024 09:54 ET | Coloplast A/S
Please see enclosed pdf.   Attachment 11122024_trading_in_shares_GL ...
Coloplast A/S - Besl
Coloplast A/S - Beslutninger på den ordinære Generalforsamling 2024
05. Dezember 2024 11:11 ET | Coloplast A/S
I dag, den 5. december 2024, har Coloplast A/S afholdt ordinær generalforsamling, hvor følgende beslutninger blev vedtaget: Årsrapporten for regnskabsåret 2023/24 blev godkendt.Forslag om...
Coloplast A/S - Deci
Coloplast A/S - Decisions at the Annual General Meeting 2024
05. Dezember 2024 11:11 ET | Coloplast A/S
Today, 5 December 2024, Coloplast A/S held its Annual General Meeting, at which the following resolutions were adopted: The annual report for the financial year 2023/24 was approved.Distribution of...
Coloplast frasælger
Coloplast frasælger kerneprodukter i hudplejeforretningen
04. Dezember 2024 07:01 ET | Coloplast A/S
Frasalget sker som led i et strategisk initiativ, der skal forenkle driften og forbedre lønsomheden i forretningsområdet Avanceret Sårpleje. Omsætningen fra de frasolgte produkter i...
Coloplast divests co
Coloplast divests core Skin Care product portfolio
04. Dezember 2024 07:01 ET | Coloplast A/S
The divestment is part of a strategic initiative to simplify business operations and improve profitability in the Advanced Wound Care business area. Revenue from the core Skin Care business amounted...
Coloplast logo.JPG
Kerecis included on the list of covered products for Diabetic Foot Ulcers in the final LCD policy
14. November 2024 08:22 ET | Coloplast A/S
On 14 November 2024, the U.S. Centers for Medicare & Medicaid Services (CMS) issued a final Local Coverage Determination (LCD)1 policy regarding skin substitute grafts/cellular and tissue-based...
Coloplast A/S - Indk
Coloplast A/S - Indkaldelse til ordinær generalforsamling 2024
12. November 2024 06:01 ET | Coloplast A/S
  Den ordinære generalforsamling i Coloplast A/S afholdestorsdag den 5. december 2024 kl. 15:30på Coloplast A/S’ adresse, Holtedam 3 (Aage Louis-Hansen Auditorium), Humlebæk, Danmark.Indkaldelsen...
Coloplast A/S - Noti
Coloplast A/S - Notice of Annual General Meeting 2024
12. November 2024 06:01 ET | Coloplast A/S
The Annual General Meeting of Coloplast A/S will be held onThursday, 5 December 2024 at 3:30 pm CETat the premises of Coloplast A/S, Holtedam 3 in Humlebæk (the Aage Louis-Hansen Auditorium),...
Coloplast A/S - Annu
Coloplast A/S - Annual Report 2023/24 & Remuneration Report 2023/24
05. November 2024 01:28 ET | Coloplast A/S
Coloplast A/S - Annual Report 2023/24 & Remuneration Report 2023/24 FY 2023/24 organic growth of 8% and 27% EBIT margin1. Reported revenue in DKK grew 10% to DKK 27,030 million. Organic...